Evidence map›Paper›PMID 38887855›Full record

ReviewJournal of clinical laboratory analysis2024

Novel Germline KIT Variants in Families With Severe Piebaldism: Case Series and Literature Review.

Yuanyuan Zhang, Haiming Gao, Lu Zhang, Yunjing Zhao, Chuang Qiu, Xiaoliang Liu

Abstract readCase ReportsReview
In one paragraph

Review in Journal of clinical laboratory analysis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuanyuan ZhangDepartment of Clinical Genetics, Shengjing Hospital of China Medical University, Shenyang, China.
Haiming GaoDepartment of Clinical Genetics, Shengjing Hospital of China Medical University, Shenyang, China.
Lu ZhangDepartment of Clinical Genetics, Shengjing Hospital of China Medical University, Shenyang, China.
Yunjing ZhaoDepartment of Developmental Pediatrics, Shengjing Hospital of China Medical University, Shenyang, China.
Chuang QiuDepartment of Orthopedics, Shengjing Hospital of China Medical University, Shenyang, China.
Xiaoliang LiuDepartment of Clinical Genetics, Shengjing Hospital of China Medical University, Shenyang, China.ORCID https://orcid.org/0000-0001-8653-0907

Funding

345 Talents of Shengjing Hospital M1395General project of Shengjing Hospital M1116General project of Shengjing Hospital M1643National Natural Science Foundation of China 32300488Natural Science Foundation of Liaoning Province 2022-MS-208
6 · The paper itself

Abstract

introductionPiebaldism is a rare autosomal dominant disorder characterized by congenital white forelock and depigmented patches, which is most commonly caused by deleterious variants in the KIT gene.

methodsFour KIT variants were identified in a piebaldism case series by whole-exome sequencing. Functional experiments, including in vitro minigene reporter assay and enzyme-linked immunosorbent assay, were carried out to elucidate the pathogenicity of the variants. The genotype-phenotype correlation was summarized through extensive literature reviewing.

resultsAll the four cases had severe piebaldism presented with typical white forelock and diffuse depigmentation on the ventral trunk and limbs. Four germline variants at the tyrosine kinase (TK) domains of the KIT gene were identified: two novel variants c.1990+1G>A (p.Pro627_Gly664delinsArg) and c.2716T>C (p.Cys906Arg), and two known variants c.1879+1G>A (p.Gly592_Pro627delinsAla) and c.1747G>A (p.Glu583Lys). Both splicing variants caused exon skipping and inframe deletions in the TK1 domain. The missense variants resided at the TK1 and TK2 domains respectively impairing PI3K/AKT and MAPK/ERK signaling pathways, the downstream of KIT. All severe cases were associated with variants in the TK domains, eliciting a major dominant-negative mechanism of the disease.

conclusionOur data expand the mutation spectrum of KIT, emphasized by a dominant-negative effect of variants in the critical TK domains in severe cases. We also share the experience of prenatal diagnosis and informed reproductive choices for the affected families.

Indexed as

Germ-Line MutationPiebaldismProto-Oncogene Proteins c-kitExome SequencingFemaleHumansInfantMalePedigreeKIT protein, humanProto-Oncogene Proteins c-kitdepigmentationgene variantKITpiebaldism

Identifiers

PMID38887855
PMCPMC11252829

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.